Quality control and auditing, Auditing

Research and development

Panorama Ltd manufactures and distributes a wide range of general pharmaceutical products. Selected audited data for the reporting period ended 31 December 2011 are as follows:

Gross profit $17,600,000

Profit before tax 1,700,000

Income tax expense 500,000

Profit for the period 1,200,000

Total assets:

Current 7,300,000

Non-current 11,500,000

The company uses a standard mark-up on cost.

From your audit files, you ascertain that total research and development expenditure for the year amounted to $4,700,000. This amount is substantially higher than in previous years and has eroded the profitability of the company. Mr Paniq, the company's finance director, has asked for your firm's advice on whether it is acceptable accounting practice for the company to carry forward any of this expenditure to a future accounting period.

Your audit files disclose that the main reason for the significant increase in research and development costs was the introduction of a planned 5-year laboratory program to attempt to find an antidote for the common cold. The following items were included in research and development costs for the year.

(a) Costs to test a new tamper-proof dispenser pack for the company's major selling line (20% of sales) of antibiotic capsules - $760,000. The new packs are to be introduced in the 2012 financial year.

(b) Experimental costs to convert a line of headache powders to liquid form - $590,000. The company hopes to phase out the powder form if the tests to convert to the stronger and better handling liquid form prove successful.

(c) Quality control required by stringent company policy and by law on all items of production for the year - $750,000.

(d) Costs of a time and motion study aimed at improving production efficiency by redesigning plant layout of existing equipment - $50,000.

(e) Construction and testing of a new prototype machine for producing hypodermic needles - $200,000. Testing has been successful to date and is nearing completion. Hypodermic needles accounted for 1% of the company's sales in the current year, but it is expected that the company's market share will increase following introduction of this new machine.

Posted Date: 2/18/2013 5:10:21 AM | Location : United States







Related Discussions:- Quality control and auditing, Assignment Help, Ask Question on Quality control and auditing, Get Answer, Expert's Help, Quality control and auditing Discussions

Write discussion on Quality control and auditing
Your posts are moderated
Related Questions
With reference to the case study business, plan an audit. You should make specific reference in your plan to: Scope of the audit Materiality Risk factors including fra

I need a 5 schedules like the sample on the attachment please follow the Instructions you will see in the instructions attachments 4 companies and you have to choose 5th one by yo

Are you able to help me my advanced auditing assignment? It is Tuesday and it is due Friday. I have worked hard on it but I am struggling with it. Carmen

QUESTION: (a) The auditor should get relevant and reliable audit evidence sufficient to enable him to draw reasonable conclusions therefrom: (i) What do you understand by

The Need for an Audit If you take an example of a modern large liability company, we can clearly distinguish between the providers of funds and those who control those funds. The

Co-operative Societies and Parastatals Co-operative Societies An audit in this case is carried out as a general audit except you should notice that the auditor is appoi

Insurance Companies Authoritative documents involved as: The Insurance Act The Companies Act IFRS 4 Insurance Contracts The major legislation governing insu

List the internal controls that should be in effect solely because a EDP system is employed, classifing them as (1) Those controls pertaining to input of information and (2) All ot

Assertions about disclosure Assertions about disclosure and presentation : a) Rights and Occurrence and obligations -disclosed transactions and events and other issues

Irregularities: Irregularities can be explained as intentional distortions of financial statements for whatever reason and also as misappropriation of possessions whether or no